<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[A recent study evaluates the efficacy of two antimicrobial agents, cefiderocol (CFDC) and levofloxacin (LVFX), as treatments for severe hemorrhagic pneumonia caused by the multidrug-resistant bacterium Stenotrophomonas maltophilia.]]></title><description><![CDATA[<p>A recent study evaluates the efficacy of two antimicrobial agents, cefiderocol (CFDC) and levofloxacin (LVFX), as treatments for severe hemorrhagic pneumonia caused by the multidrug-resistant bacterium Stenotrophomonas maltophilia. <br /><a href="https://mastodon.social/tags/Pharmacology" rel="tag">#<span>Pharmacology</span></a> <a href="https://mastodon.social/tags/InfectiousDiseases" rel="tag">#<span>InfectiousDiseases</span></a> <a href="https://mastodon.social/tags/Microbiology" rel="tag">#<span>Microbiology</span></a> <a href="https://mastodon.social/tags/Medicine" rel="tag">#<span>Medicine</span></a> <a href="https://mastodon.social/tags/sflorg" rel="tag">#<span>sflorg</span></a> <br /><a href="https://www.sflorg.com/2026/05/phar05112601.html" rel="nofollow noopener"><span>https://www.</span><span>sflorg.com/2026/05/phar0511260</span><span>1.html</span></a></p>]]></description><link>https://postcall.pub/topic/4a1c6476-b085-4163-b4d1-4bb2de1311b7/a-recent-study-evaluates-the-efficacy-of-two-antimicrobial-agents-cefiderocol-cfdc-and-levofloxacin-lvfx-as-treatments-for-severe-hemorrhagic-pneumonia-caused-by-the-multidrug-resistant-bacterium-stenotrophomonas-maltophilia.</link><generator>RSS for Node</generator><lastBuildDate>Mon, 25 May 2026 01:30:59 GMT</lastBuildDate><atom:link href="https://postcall.pub/topic/4a1c6476-b085-4163-b4d1-4bb2de1311b7.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 11 May 2026 11:25:24 GMT</pubDate><ttl>60</ttl></channel></rss>